Omnicell, Inc.OMCLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -1.92% |
| 2024 | -3.08% |
| 2023 | -11.13% |
| 2022 | 38.64% |
| 2021 | 7.92% |
| 2020 | 2.21% |
| 2019 | 5.86% |
| 2018 | -1.79% |
| 2017 | 14.23% |
| 2016 | 64.39% |